DK651588D0 - Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia - Google Patents

Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia

Info

Publication number
DK651588D0
DK651588D0 DK651588A DK651588A DK651588D0 DK 651588 D0 DK651588 D0 DK 651588D0 DK 651588 A DK651588 A DK 651588A DK 651588 A DK651588 A DK 651588A DK 651588 D0 DK651588 D0 DK 651588D0
Authority
DK
Denmark
Prior art keywords
preparation
fibromyalgia
compound
treatment
application
Prior art date
Application number
DK651588A
Other languages
English (en)
Other versions
DK174506B1 (da
DK651588A (da
Inventor
Stephen M Sorensen
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK651588D0 publication Critical patent/DK651588D0/da
Publication of DK651588A publication Critical patent/DK651588A/da
Application granted granted Critical
Publication of DK174506B1 publication Critical patent/DK174506B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198806515A 1987-11-23 1988-11-22 Anvendelse af en forbindelse til fremstilling af et farmaceutisk præparat til behandling af fibromyalgia DK174506B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12375587A 1987-11-23 1987-11-23
US12375587 1987-11-23

Publications (3)

Publication Number Publication Date
DK651588D0 true DK651588D0 (da) 1988-11-22
DK651588A DK651588A (da) 1989-05-24
DK174506B1 DK174506B1 (da) 2003-04-28

Family

ID=22410686

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806515A DK174506B1 (da) 1987-11-23 1988-11-22 Anvendelse af en forbindelse til fremstilling af et farmaceutisk præparat til behandling af fibromyalgia

Country Status (6)

Country Link
EP (1) EP0317933A3 (da)
JP (1) JPH02138173A (da)
KR (1) KR890007735A (da)
AU (1) AU605385B2 (da)
DK (1) DK174506B1 (da)
ZA (1) ZA888572B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004980A (en) * 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
JP2869512B2 (ja) * 1990-06-01 1999-03-10 メレルダウファーマスーティカルズ インコーポレイテッド （＋）―α―（２，３―ジメトキシフェニル）―１―［２―（４―フルオロフェニル）エチル］―４―ピペリジンメタノール
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
US6939879B2 (en) 1998-08-28 2005-09-06 Aventis Pharmaceuticals Inc. Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia
US6277864B1 (en) 1998-08-28 2001-08-21 Aventis Pharmaceuticals Inc. Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA864772B (en) * 1985-07-02 1987-02-25 Merrell Dow Pharma Novel chemical compounds

Also Published As

Publication number Publication date
AU2564688A (en) 1989-05-25
KR890007735A (ko) 1989-07-05
AU605385B2 (en) 1991-01-10
EP0317933A3 (en) 1990-09-12
JPH02138173A (ja) 1990-05-28
ZA888572B (en) 1989-08-30
DK174506B1 (da) 2003-04-28
DK651588A (da) 1989-05-24
EP0317933A2 (en) 1989-05-31

Similar Documents

Publication Publication Date Title
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
DK574287D0 (da) Anvendelse af et retinoid til fremstilling af et medikament til forebyggelse af glucocorticoidfremkaldt hudatrofi
DK615988A (da) Fremgangsmaade til fremstilling af et afsvovlingsmiddel
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK390181A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til frmme af saarheling
DK308488D0 (da) Farmaceutisk praeparat til behandling af en retrovirusinfektion
DK689188D0 (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
DK32290D0 (da) Anvendelse af 8'-acylerede derivater af mellemproduktforbindelsen mb-530a til fremstilling af et laegemiddel til behandling af hypercholesterolaemi
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK418386A (da) Kombinationspraeparat til behandling af malaria
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK425287A (da) Fremstilling af et farmaceutisk praeparat til behandling af kongestivt hjertesvigt
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
FI92396B (fi) Uusi menetelmä valmistaa metyleenidioksifenantreeniyhdisteitä
DK484186A (da) Fremgangsmaade til fremstilling af et praeparat til behandling af psoriasis
DK155682A (da) Fremgangsmaade til fremstilling af et psykotropt laegemiddel
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK473188D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK234588A (da) Fremgangsmaade til fremstilling af et renset bariumsalt
DK68790A (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK0421319T3 (da) Fremgangsmåde til fremstilling af et aromastof
NO863225L (no) Analogifremgangsmaate for fremstilling av et terapeutisk virksomt benzodioxepan.

Legal Events

Date Code Title Description
PUP Patent expired